06.01.2014 Views

Annual Report 2010 - Hannover Re

Annual Report 2010 - Hannover Re

Annual Report 2010 - Hannover Re

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

13 October <strong>2010</strong> that taxation of foreign sourced investment<br />

income recorded by Irish subsidiaries was not permissible, we<br />

were able to release provisions that had been constituted in<br />

this regard. The core of the legal dispute revolved around the<br />

question of whether investment income generated by a reinsurance<br />

subsidiary based in Ireland was subject to taxation at<br />

the parent company in Germany. The ruling of the BFH confirmed<br />

the decision in the first instance of the Lower Saxony<br />

Fiscal Court in <strong>Hannover</strong>. Against this backdrop, all tax risks<br />

were reassessed. This resulted in an increase of altogether<br />

EUR 112.2 million in Group net income.<br />

In December <strong>2010</strong> we reached agreement on the sale of all<br />

operational companies of our US subsidiary Clarendon Insurance<br />

Group, Inc., New York, to the Bermuda-based Enstar<br />

Group Ltd., Hamilton. The transaction, which is still subject to<br />

the customary foreign regulatory approvals, is expected to<br />

close in the second quarter of 2011. The purchase price of<br />

Clarendon, which has been in run-off since 2005, is equivalent<br />

to EUR 162.5 million before final price determination. The sale<br />

enables us to reduce material risks for our company, including<br />

for example those connected with reinsurance recoverables<br />

on unpaid claims. We are also able to eliminate operational<br />

risks associated with the run-off of a US primary insurer as<br />

well as considerable administrative expenses that would have<br />

been incurred in subsequent years. In accordance with IFRS<br />

accounting practice, the sale of Clarendon produces a charge<br />

of EUR 69.2 million to our Group net income in the year under<br />

review, which is recognised in the non-life reinsurance business<br />

group.<br />

The operating profit (EBIT) booked by <strong>Hannover</strong> <strong>Re</strong> increased<br />

to EUR 1.2 billion (EUR 1.1 billion) in <strong>2010</strong>. The previous year<br />

had been influenced by positive special effects in life and<br />

health reinsurance amounting to EUR 144.7 million. These<br />

derived from the acquisition of the ING life reinsurance portfolio<br />

as well as the reversal of unrealised losses on deposits<br />

held by US cedants on behalf of <strong>Hannover</strong> <strong>Re</strong> (ModCo). The<br />

Group net income of EUR 748.9 million once again surpassed<br />

the outstanding level of the previous year (EUR 733.7 million).<br />

A very healthy underlying operating profit and favourable nonrecurring<br />

effects associated with the decision of the Federal<br />

Fiscal Court were both factors in this positive performance.<br />

Earnings per share amounted to EUR 6.21 (EUR 6.08).<br />

Our shareholders’ equity excluding minority interests also developed<br />

particularly favourably, rising in the year under review<br />

from EUR 3.7 billion to EUR 4.5 billion. The policyholders’<br />

surplus increased from EUR 5.6 billion to EUR 7.0 billion. The<br />

return on equity for <strong>2010</strong> came in at 18.2%.<br />

In September <strong>2010</strong> we used the relatively low interest rate<br />

level to place subordinated hybrid debt of EUR 500 million on<br />

the European capital market. The bond, which has a term of<br />

30 years, serves to further optimise our capital structure as<br />

well as to back future growth with the necessary capital resources.<br />

We use retrocession, i.e. the passing on of portions of our<br />

covered risks to other reinsurers, as a means of risk reduction.<br />

In the course of the year the reinsurance recoverables on unpaid<br />

claims – i.e. receivables due to us from our retrocessionaires<br />

– decreased to EUR 1.0 billion (EUR 1.7 billion). Of this<br />

total reduction, an amount of EUR 0.8 billion results from the<br />

sale of Clarendon. We continue to attach considerable importance<br />

to the quality of our retrocessionaires: 92.4% of the companies<br />

with which we maintain such business relations have<br />

an investment grade rating of “BBB” or better from Standard<br />

& Poor’s.<br />

Our business groups<br />

In the following sections we discuss the development of the<br />

financial year on the basis of our two strategic business<br />

groups, namely non-life reinsurance and life/health reinsurance.<br />

Supplementary to the information provided here, the<br />

segmental report contained in the annual financial statement<br />

shows the key balance sheet items and profit components broken<br />

down into the individual business groups.<br />

20 Management report OUR Business Groups<br />

<strong>Hannover</strong> <strong>Re</strong> Group annual report <strong>2010</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!